@article{ace2b9bf65d8478891d1278452840ba7,
title = "Repurposing CD8+ T cell immunity against SARS-CoV-2 for cancer immunotherapy: a positive aspect of the COVID-19 pandemic?",
abstract = "The COVID-19 pandemic has afflicted most countries on the planet. As a result, immunity against SARS-CoV-2, induced via natural infections or imminent vaccinations, is expected to develop in a large fraction of the global population. Here, we propose to exploit SARS-CoV-2-specific CD8+ T cells for cancer immunotherapy strategies.",
keywords = "CD8 T cell epitopes, SARS-CoV-2, antigen spreading, antiviral immunity, cancer immunotherapy",
author = "Shashi Gujar and Pol, {Jonathan G.} and Youra Kim and Guido Kroemer",
note = "Publisher Copyright: {\textcopyright} 2020, {\textcopyright} 2020 The Author(s). Published with license by Taylor & Francis Group, LLC.",
year = "2020",
month = jan,
day = "1",
doi = "10.1080/2162402X.2020.1794424",
language = "English",
volume = "9",
journal = "OncoImmunology",
issn = "2162-4011",
number = "1",
}